A systematic review of optical coherence tomography findings in adults with mild traumatic brain injury.
Hannah S LyonsMatilde SassaniYousef HyderJames L MitchellMark ThallerMiss Susan P MollanAlexandra Jean Sinclairnull nullRichard James BlanchPublished in: Eye (London, England) (2024)
Mild traumatic brain injury (mTBI) is common with many patients suffering disabling long-term sequelae, with visual symptoms frequently reported. There are no objective biomarkers of mTBI that are routinely used in clinical practice. Optical coherence tomography (OCT) has been used in mTBI research, as it enables visualisation of the neuroretina, allowing measurement of the retinal nerve fibre layer and ganglion cell layer. This systematic review aims to appraise the available literature and assess whether there are significant changes within the retinal nerve fibre layer and ganglion cell layer in subjects after mTBI. A systematic review was carried out in accordance with PRISMA guidelines and registered with PROSPERO (Number: CRD42022360498). Four databases were searched for relevant literature published from inception until 1 September 2022. Abstracts and full texts were screened by three independent reviewers. Initial screening of databases yielded 341 publications, of these, three fulfilled all the criteria for inclusion. All three studies showed thinning of the retinal nerve fibre layer, whereas there were no significant changes in the ganglion cell layer. This systematic review demonstrated that thinning of the retinal nerve fibre layer (but not of the ganglion cell layer) is associated with mTBI. It provides preliminary evidence for the use of the retinal nerve fibre layer as a potential biomarker of damage to the visual system in mTBI. Further prospective longitudinal studies ensuring uniform diagnosis and accurate phenotyping of mTBI are needed to understand the effects on the visual system and potential of OCT as a prognostic biomarker.
Keyphrases
- mild traumatic brain injury
- optical coherence tomography
- optic nerve
- systematic review
- diabetic retinopathy
- single cell
- meta analyses
- cell therapy
- clinical practice
- randomized controlled trial
- neuropathic pain
- high resolution
- end stage renal disease
- stem cells
- peripheral nerve
- newly diagnosed
- chronic kidney disease
- physical activity
- artificial intelligence
- oxidative stress
- mesenchymal stem cells
- big data
- risk assessment
- mass spectrometry
- sleep quality
- spinal cord injury
- machine learning
- cross sectional
- patient reported outcomes